Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell surface and intracellular proteins encompass a vast array of molecular structures essential for the survival, replication, and pathogenicity of bacteria, viruses, fungi, and parasites (Nature Reviews Microbiology, 2007). Surface proteins, such as penicillin-binding proteins and adhesins, are critical for maintaining structural integrity and facilitating host cell attachment, making them primary targets for many antibiotics (StatPearls, 2023). Intracellular proteins, including ribosomes, DNA gyrase, and various metabolic enzymes, govern the fundamental processes of genetic expression and energy production (NCBI, 2021). Therapeutic intervention typically involves small molecules or biologics that bind to these proteins to inhibit their function, leading to microbial stasis or death. However, the broad nature of this category reflects the diversity of antimicrobial therapy, where specificity is required to avoid cross-reactivity with host proteins and to mitigate the development of resistance (Microbiology Spectrum, 2019).
Drugs targeting these proteins typically act by inhibiting essential life processes such as cell wall biosynthesis (e.g., beta-lactams), nucleic acid replication (e.g., fluoroquinolones), or protein translation (e.g., macrolides), or by disrupting the integrity of the microbial cell membrane (StatPearls, 2023; Nature Reviews Microbiology, 2007).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell surface and intracellular proteins.